An initiative for harmonization of pathology across the United Kingdom has recommended an interval for sodium of 133-146mmol/L at all ages. Methods:To assess the validity of this, the laboratory database was interrogated for all renal profiles (sodium, potassium, urea and creatinine) for children presenting to primary care over a 13-year period. While the primary interest was in sodium results,
sufficient current data were also available for potassium and creatinine and so these were included for study. The electrolyte results were filtered to include only normal renal function and the remaining data were analysed for age-related differences. Results:Sodium concentrations were observed to be lower for infants (1-5 years of selleckchem age) with a mean of 138mmol/L, increasing towards adult concentrations (mean 140mmol/L) Fludarabine by teenage years. A similar pattern was seen for potassium results, and creatinine was seen to increase with age. At all ages, the distributions of sodium concentrations measured in this population were observably tighter than the interval of 133-146mmol/L recommended by Pathology Harmony. Conclusions:We suggest that this
interval is too wide, and more work is needed to establish more appropriate paediatric ranges.”
“Fructose consumption ill the USA has increased over the past three decades. During this time, obesity, insulin resistance and the metabolic syndrome have also find more increased in prevalence. While diets high in fructose have been shown to promote insulin resistance and increase TAG concentrations in animals, there are insufficient data available regarding the long-term metabolic effects of fructose consumption in humans. The objective of the present study was to investigate the metabolic effects of 10-week consumption of fructose-sweetened beverages in human subjects under energy-balanced conditions in a controlled research setting. Following a 4-week weight-maintaining
complex carbohydrate diet, seven over weight or obese (BMI 26.8-33.3 kg/m(2)) postmenopausal women were fed an isoenergetic intervention diet, which included a fructose-sweetened beverage with each meal. for 10 weeks. The intervention diet provided 15% of energy from protein, 30% from fat and 55% from carbohydrate (30% complex carbohydrate, 25% fructose). Fasting and postprandial glucose, insulin, TAG and apoB concentrations were measured. Fructose consumption increased fasting glucose concentrations and decreased meal-associated glucose and insulin responses (P=0.0002, P=0.007 and P=0.013, respectively). Moreover, after 10 weeks of fructose consumption, 1411 postprandial TAG profiles were significantly increased, with the area under the curve at 10 weeks being 141% higher than at baseline (P=0.04). Fructose also increased fasting apoB concentrations by 19% (P=0.043 v. baseline).